Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism.

BACKGROUND Cell-free DNA from dying cells recently has been discovered in human blood plasma. In experiments performed on animals and humans, we examined whether this cell-free DNA can cross the kidney barrier and be used as a diagnostic tool. METHODS Mice received subcutaneous injections of either human Raji cells or purified (32)P-labeled DNA. DNA was isolated from urine and analyzed by measurement of radioactivity, agarose gel electrophoresis, and PCR. In humans, the permeability of the kidney barrier to polymeric DNA was assessed by detection in urine of sequences that were different from an organism bulk nuclear DNA. RESULTS In the experiments on laboratory animals, we found that approximately 0.06% of injected DNA was excreted into urine within 3 days in a polymeric form and that human-specific ALU: sequences that passed through the kidneys could be amplified by PCR. In humans, male-specific sequences could be detected in the urine of females who had been transfused with male blood as well as in DNA isolated from urine of women pregnant with male fetuses. K-ras mutations were detected in the urine of patients with colon adenocarcinomas and pancreatic carcinomas. CONCLUSIONS The data suggest that the kidney barrier in rodents and humans is permeable to DNA molecules large enough to be analyzed by standard genetic methodologies.

[1]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.

[2]  F. A. Benko,et al.  Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. , 1997, British Journal of Cancer.

[3]  Y. Kodera,et al.  Detection of Tumor DNA in Serum of Colorectal Cancer Patients , 2002, Japanese journal of cancer research : Gann.

[4]  Y. Lo,et al.  Rapid clearance of fetal DNA from maternal plasma. , 1999, American journal of human genetics.

[5]  M. Ishizawa,et al.  Simple procedure of DNA isolation from human serum. , 1991, Nucleic acids research.

[6]  P. Gennes,et al.  Passive entry of a DNA molecule into a small pore. , 1999 .

[7]  Y. Lo,et al.  Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. , 1999, Clinical chemistry.

[8]  M Monden,et al.  Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[10]  H. Kaatsch,et al.  Improved DNA typing of human urine by adding EDTA , 1999, International Journal of Legal Medicine.

[11]  Y. Lo Fetal RhD genotyping from maternal plasma. , 1999, Annals of medicine.

[12]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[13]  T K Lau,et al.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.

[14]  J. Pourrat,et al.  Plasma DNA as cell death marker in elderly patients. , 1993, Gerontology.

[15]  J. Goedert,et al.  Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. , 2000, Journal of the National Cancer Institute.

[16]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[17]  N M Hjelm,et al.  Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. , 1998, The New England journal of medicine.

[18]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[19]  F. Bischoff,et al.  Noninvasive Determination of Fetal RhD Status Using Fetal DNA in Maternal Serum and PCR , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.

[20]  D. Labuda,et al.  Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Yamada,et al.  A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides. , 1986, Nucleic acids research.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[24]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[25]  S. Leung,et al.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.

[26]  D. Swinkels,et al.  Detection of tumour DNA in serum of colorectal cancer patients. , 1997, Scandinavian journal of clinical and laboratory investigation.

[27]  J. Pourrat,et al.  Extracellular DNA in blood and urine as a potential marker for cytotoxicity and nephrotoxicity in the mouse. , 1990, Renal failure.